Hem › Dermatomyosit › Maryland
Kliniska studier för Dermatomyosit i Maryland
9 studier för Dermatomyosit söker deltagare vid platser i Maryland.
Städer i Maryland
Officiell studietext (engelska)
FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 2
Ålder 18 till 60 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07111065Environmental Risk Factors for the Anti-synthetase Syndrome
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 2 till 100 · Alla kön · Uppdaterad 28 sep. 2026 · NCT01276470A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Baltimore
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06455449Natural History of Inflammatory Muscle Diseases
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 2 till 120 · Alla kön · Uppdaterad 24 sep. 2026 · NCT05738824Adult and Juvenile Myositis
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 2 till 100 · Alla kön · Uppdaterad 24 sep. 2026 · NCT00017914Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT03816345RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- National Institutes of Health - Accepting Adult and Juvenile Patients, Bethesda
RekryterarFas 2/3
Ålder 6 till 75 · Alla kön · Uppdaterad 17 sep. 2026 · NCT06154252A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Johns Hopkins Hospital, Baltimore
RekryterarFas 1
Ålder 18 till 74 · Alla kön · Uppdaterad 10 sep. 2026 · NCT07085104Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Johns Hopkins University, Baltimore
RekryterarFas 1
Ålder 18 till 85 · Alla kön · Uppdaterad 22 juli 2026 · NCT06371417Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.